<!DOCTYPE html>
<html><head>
		<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
		<meta http-equiv="Content-Security-Policy" content="script-src 'none'; media-src 'none'">
		<title>Informe de Zotero</title>
		<link rel="stylesheet" type="text/css" href="data:text/css;base64,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">
		<link rel="stylesheet" type="text/css" media="screen,projection" href="data:text/css;base64,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">
		<link rel="stylesheet" type="text/css" media="print" href="data:text/css;base64,Ym9keSB7Cglmb250OiAxMnB0ICJUaW1lcyBOZXcgUm9tYW4iLCBUaW1lcywgR2VvcmdpYSwgc2VyaWY7CgltYXJnaW46IDA7Cgl3aWR0aDogYXV0bzsKCWNvbG9yOiBibGFjazsKfQoKLyogUGFnZSBCcmVha3MgKHBhZ2UtYnJlYWstaW5zaWRlIG9ubHkgcmVjb2duaXplZCBieSBPcGVyYSkgKi8KaDEsIGgyLCBoMywgaDQsIGg1LCBoNiB7CglwYWdlLWJyZWFrLWFmdGVyOiBhdm9pZDsKCXBhZ2UtYnJlYWstaW5zaWRlOiBhdm9pZDsKfQoKdWwsIG9sLCBkbCB7CglwYWdlLWJyZWFrLWluc2lkZTogYXZvaWQ7Cgljb2xvci1hZGp1c3Q6IGV4YWN0Owp9CgpoMiB7Cglmb250LXNpemU6IDEuM2VtOwoJbGluZS1oZWlnaHQ6IDEuM2VtOwp9CgphIHsKCWNvbG9yOiAjMDAwOwoJdGV4dC1kZWNvcmF0aW9uOiBub25lOwp9Cg==">
	</head>
	<body>
		<ul class="report combineChildItems">
			<li id="item_WVSPRZFB" class="item journalArticle">
			<h2>Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition</h2>
				<table>
					<tbody><tr>
						<th>Tipo de elemento</th>
						<td>Artículo de revista académica</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Frederick S. Barrett</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Theresa M. Carbonaro</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Ethan Hurwitz</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Matthew W. Johnson</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Roland R. Griffiths</td>
					</tr>
					<tr>
					<th>Resumen</th>
						<td>OBJECTIVES: Classic psychedelics (serotonin 2A receptor 
agonists) and dissociative hallucinogens (NMDA receptor antagonists), 
though differing in pharmacology, may share neuropsychological effects. 
These drugs, however, have undergone limited direct comparison. This 
report presents data from a double-blind, placebo-controlled 
within-subjects study comparing the neuropsychological effects of 
multiple doses of the classic psychedelic psilocybin with the effects of
 a single high dose of the dissociative hallucinogen dextromethorphan 
(DXM).
METHODS: Twenty hallucinogen users (11 females) completed neurocognitive
 assessments during five blinded drug administration sessions (10, 20, 
and 30 mg/70 kg psilocybin; 400 mg/70 kg DXM; and placebo) in which 
participants and study staff were informed that a large range of 
possible drug conditions may have been administered.
RESULTS: Global cognitive impairment, assessed using the Mini-Mental 
State Examination during peak drug effects, was not observed with 
psilocybin or DXM. Orderly and dose-dependent effects of psilocybin were
 observed on psychomotor performance, working memory, episodic memory, 
associative learning, and visual perception. Effects of DXM on 
psychomotor performance, visual perception, and associative learning 
were in the range of effects of a moderate to high dose (20 to 30 mg/70 
kg) of psilocybin.
CONCLUSIONS: This was the first study of the dose effects of psilocybin 
on a large battery of neurocognitive assessments. Evidence of delirium 
or global cognitive impairment was not observed with either psilocybin 
or DXM. Psilocybin had greater effects than DXM on working memory. DXM 
had greater effects than all psilocybin doses on balance, episodic 
memory, response inhibition, and executive control.</td>
					</tr>
					<tr>
					<th>Fecha</th>
						<td>2018-10</td>
					</tr>
					<tr>
					<th>Idioma</th>
						<td>eng</td>
					</tr>
					<tr>
					<th>Título corto</th>
						<td>Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan</td>
					</tr>
					<tr>
					<th>Catálogo de biblioteca</th>
						<td>PubMed</td>
					</tr>
					<tr>
					<th>Adicional</th>
						<td>PMID: 30062577
PMCID: PMC6162157</td>
					</tr>
					<tr>
					<th>Volumen</th>
						<td>235</td>
					</tr>
					<tr>
					<th>Páginas</th>
						<td>2915-2927</td>
					</tr>
					<tr>
					<th>Publicación</th>
						<td>Psychopharmacology</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1007/s00213-018-4981-x">10.1007/s00213-018-4981-x</a></td>
					</tr>
					<tr>
					<th>Número</th>
						<td>10</td>
					</tr>
					<tr>
					<th>Abrev. de revista</th>
						<td>Psychopharmacology (Berl)</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1432-2072</td>
					</tr>
					<tr>
					<th>Fecha de adición</th>
						<td>22/2/2024 14:06:06</td>
					</tr>
					<tr>
					<th>Modificado</th>
						<td>22/2/2024 14:06:06</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Etiquetas:</h3>
				<ul class="tags">
					<li>Hallucinogens</li>
					<li>Humans</li>
					<li>Adult</li>
					<li>Association Learning</li>
					<li>Cognition</li>
					<li>Dextromethorphan</li>
					<li>Dose-Response Relationship, Drug</li>
					<li>Double-Blind Method</li>
					<li>Female</li>
					<li>Hallucinogen</li>
					<li>Male</li>
					<li>Memory, Short-Term</li>
					<li>Psilocybin</li>
					<li>Psychedelic drug</li>
					<li>Psychomotor Performance</li>
					<li>Visual Perception</li>
					<li>Young Adult</li>
				</ul>
				<h3 class="attachments">Adjuntos</h3>
				<ul class="attachments">
					<li id="item_8R2ZIZVX">PubMed entry					</li>
					<li id="item_3NXHTVXJ">Versión aceptada					</li>
				</ul>
			</li>


			<li id="item_CSMW5GN8" class="item journalArticle">
			<h2>Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis</h2>
				<table>
					<tbody><tr>
						<th>Tipo de elemento</th>
						<td>Artículo de revista académica</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Bruno Romeo</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Laurent Karila</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Catherine Martelli</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Amine Benyamina</td>
					</tr>
					<tr>
					<th>Resumen</th>
						<td>BACKGROUND: Psychedelic drugs have shown an efficacy in some 
psychiatric disorders and have an original mechanism of action with a 
5-HT2A agonism.
AIM: The aim of this meta-analysis was to assess by a quantitative 
analysis the putative efficacy of psychedelic drugs on depressive 
symptoms and to investigate the kinetic of this efficacy.
METHODS: We searched the MEDLINE and PsycINFO databases through April 
2019, without limits on year of publication. Means and standard 
deviations were extracted to calculate standardized mean differences 
(SMD). Scores of depressive symptoms were compared with baseline scores 
at days 7, 14, and 21; weeks 4-5 and 6-8; and months 3 and 6.
RESULTS: Eight studies were included in this meta-analysis. A 
significant decrease of depressive symptoms was found from day 1 (n = 5 
studies; SMD = ‒1.4, 95% confidence interval (CI): ‒2.33 to ‒0.48, 
p = 0.003) to 6 months (n = 4 studies; SMD = ‒1.07, 95% CI: ‒1.44 to 
‒0.7, p &lt; 0.001) after psychedelic sessions. No serious adverse 
effect was reported in all included studies. A transient increase of the
 heart rate, blood systolic, and diastolic pressure were found after 
psychedelics compared with placebo.
CONCLUSION: This meta-analysis shows that psychedelic treatments were 
safe and could contribute to a rapid improvement of depressive symptoms.</td>
					</tr>
					<tr>
					<th>Fecha</th>
						<td>2020-10</td>
					</tr>
					<tr>
					<th>Idioma</th>
						<td>eng</td>
					</tr>
					<tr>
					<th>Título corto</th>
						<td>Efficacy of psychedelic treatments on depressive symptoms</td>
					</tr>
					<tr>
					<th>Catálogo de biblioteca</th>
						<td>PubMed</td>
					</tr>
					<tr>
					<th>Adicional</th>
						<td>PMID: 32448048</td>
					</tr>
					<tr>
					<th>Volumen</th>
						<td>34</td>
					</tr>
					<tr>
					<th>Páginas</th>
						<td>1079-1085</td>
					</tr>
					<tr>
					<th>Publicación</th>
						<td>Journal of Psychopharmacology (Oxford, England)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1177/0269881120919957">10.1177/0269881120919957</a></td>
					</tr>
					<tr>
					<th>Número</th>
						<td>10</td>
					</tr>
					<tr>
					<th>Abrev. de revista</th>
						<td>J Psychopharmacol</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1461-7285</td>
					</tr>
					<tr>
					<th>Fecha de adición</th>
						<td>22/2/2024 12:15:16</td>
					</tr>
					<tr>
					<th>Modificado</th>
						<td>22/2/2024 12:15:20</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Etiquetas:</h3>
				<ul class="tags">
					<li>Animals</li>
					<li>ayahuasca</li>
					<li>Blood Pressure</li>
					<li>Depression</li>
					<li>depressive symptoms</li>
					<li>Hallucinogens</li>
					<li>Heart Rate</li>
					<li>Humans</li>
					<li>meta-analysis</li>
					<li>psilocybin</li>
					<li>Psychedelics</li>
					<li>Serotonin 5-HT2 Receptor Agonists</li>
					<li>Time Factors</li>
					<li>Treatment Outcome</li>
				</ul>
				<h3 class="attachments">Adjuntos</h3>
				<ul class="attachments">
					<li id="item_35DDQ2U9">PubMed entry					</li>
				</ul>
			</li>


			<li id="item_MG8CESQ8" class="item journalArticle">
			<h2>Psychedelic Treatments for Psychiatric Disorders: A Systematic 
Review and Thematic Synthesis of Patient Experiences in Qualitative 
Studies</h2>
				<table>
					<tbody><tr>
						<th>Tipo de elemento</th>
						<td>Artículo de revista académica</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Joost J. Breeksema</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Alistair R. Niemeijer</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Erwin Krediet</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Eric Vermetten</td>
					</tr>
					<tr>
						<th class="author">Autor</th>
						<td>Robert A. Schoevers</td>
					</tr>
					<tr>
					<th>Resumen</th>
						<td>Interest in the use of psychedelic substances for the 
treatment of mental disorders is increasing. Processes that may affect 
therapeutic change are not yet fully understood. Qualitative research 
methods are increasingly used to examine patient accounts; however, 
currently, no systematic review exists that synthesizes these findings 
in relation to the use of psychedelics for the treatment of mental 
disorders.</td>
					</tr>
					<tr>
					<th>Fecha</th>
						<td>2020-09-01</td>
					</tr>
					<tr>
					<th>Idioma</th>
						<td>en</td>
					</tr>
					<tr>
					<th>Título corto</th>
						<td>Psychedelic Treatments for Psychiatric Disorders</td>
					</tr>
					<tr>
					<th>Catálogo de biblioteca</th>
						<td>Springer Link</td>
					</tr>
					<tr>
					<th>URL</th>
						<td><a href="https://doi.org/10.1007/s40263-020-00748-y">https://doi.org/10.1007/s40263-020-00748-y</a></td>
					</tr>
					<tr>
					<th>Accedido</th>
						<td>22/2/2024 12:25:26</td>
					</tr>
					<tr>
					<th>Volumen</th>
						<td>34</td>
					</tr>
					<tr>
					<th>Páginas</th>
						<td>925-946</td>
					</tr>
					<tr>
					<th>Publicación</th>
						<td>CNS Drugs</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1007/s40263-020-00748-y">10.1007/s40263-020-00748-y</a></td>
					</tr>
					<tr>
					<th>Número</th>
						<td>9</td>
					</tr>
					<tr>
					<th>Abrev. de revista</th>
						<td>CNS Drugs</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1179-1934</td>
					</tr>
					<tr>
					<th>Fecha de adición</th>
						<td>22/2/2024 12:25:26</td>
					</tr>
					<tr>
					<th>Modificado</th>
						<td>22/2/2024 12:25:31</td>
					</tr>
				</tbody></table>
				<h3 class="attachments">Adjuntos</h3>
				<ul class="attachments">
					<li id="item_NSWV2Z9B">Full Text PDF					</li>
				</ul>
			</li>

		</ul>
	
</body></html>